Clinical trial
Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant…
NCT00176059 · University of Giessen, Other · Completed
Key facts
| NCT number | NCT00176059 |
|---|---|
| Title | Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients |
| Official title | Immunoglobulin Induction Therapy in Renal Transplant Recipients on Tacrolimus/Azathioprine or Tacrolimus/MMF: Effects on Th1, Th2, B Cell-/Monokine Responses and Immunoregulatory Autoantibody Levels |
| Lead sponsor | University of Giessen, Other |
| Collaborators | Heidelberg University Astellas Pharma Inc Industry Hoffmann-La Roche Aventis Pharmaceuticals |
| Status | Completed |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Renal Failure, Chronic, Renal Transplantation |
| Intervention type | Drug, Procedure |
| Interventions | intravenous immunoglobulins (IVIG), kidney transplantation |
| Enrollment | 50 |
| Start date | Oct 1, 2001 |
| Completion | May 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | May 10, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: